Taken together, these data indicate that TRAIL promotes EMT-induced cell metastasis through ERK/STAT3 signaling pathway activation and inducing PD-L1 expression in ESCC in vivo. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.